Skip to content

Neogen NEOG Change in Other Assets

Change in Other Assets at other companies

Zoetis logo
ZoetisZTS
$66M+43.5%
NeoGenomics logo
NeoGenomicsNEO
$1.4M-55.1%
Phibro Animal Health logo
Phibro Animal HealthPAHC
-$579K
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
-$5.25M-90.9%
Opko Health logo
Opko HealthOPK
-$6.97M-155%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
-$1.43M+36.1%

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$2B+93.1%
Enterprise value$2.63B+45.5%
P/S2.3×+1.1×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's change in other assets?
Neogen (NEOG) reported change in other assets of $5.57M in Q4 2025.
What is the long-term trend for Neogen's change in other assets?
Over 2 years (2021 to 2024), Neogen's change in other assets has grown at a 76.7% compound annual growth rate (CAGR), from $3.56M to -$11.11M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.